MedPath

Anxiety Reduction in TAVI using Virtual Reality Trial

Recruiting
Conditions
Anxiety during TAVI
Anxiety during transcatheter aortic valve replacement procedure under local anesthesia
10046973
Registration Number
NL-OMON50951
Lead Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
75
Inclusion Criteria

o Age * 18 years
o Symptomatic severe aortic stenosis
o Indication for transfemoral TAVI under local anaesthesia per local heart team
consensus
o Patient is able to understand and sign written informed consent
o Patient speaks Dutch, German or English

Exclusion Criteria

o Need for emergent TAVI
o Need for planned concomitant cardiac intervention during index procedure
o History of TAVI under local anesthesia/conscious sedation
o Chronic use of benzodiapines, opioids, pregabalin or antidepressants
o History of opioid use (within 8-30 days prior to randomization)
o Claustrophobia
o Any psychiatric illness diagnosed by a psychiatrist or psychologist
o Blindness or severe visual impairment despite visual aid (glasses, contact
lenses)
o Epilepsy
o Extensive cognitive impairment (MMSE <21 or as diagnosed by geriatrician)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Primary endpoint: Procedural anxiety assessed on a visual analogue scale (VAS)<br /><br>directly post-procedure.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Patient procedural satisfaction<br /><br>Change in anxiety pre- vs. postprocedure<br /><br>Procedural pain assessed on a VAS directly post-procedure<br /><br>Procedural sedative use and dosage<br /><br>Procedural analgesic use and dosage<br /><br>Procedural nausea<br /><br>Procedural vomiting<br /><br>Admission time </p><br>
© Copyright 2025. All Rights Reserved by MedPath